Ocupharm diagnostic S.L

Company specialized in assistance and help with the research, development and regulation of ophthalmological products.

Patents of the “Ocupharm Diagnostics”

These products have been developed from patents generated in the R+D+I department. In this same direction, different patents have currently been registered for the diagnosis of acanthamoeba, dry eye, vehicle delivery and improvement of drug administration via the ophthalmic route, and food supplements.

  1. PUBLICATION ES2932995. Eye parasite detection system.
  2. PUBLICATION ES2529369. Use of the compound calcium 2,5-Dihydroxybenzenesulfonate (calcium dobesilate) for the preparation of a medication for the treatment of achondroplasia.
  3. PUBLICATION ES2735642. Food product for ocular hypertension and glaucoma.
  4. PUBLICATION ES2469290. Improvement in the topical application of ocular drugs through the administration of nucleotides.
  5. PUBLICATION ES2724933. Combined therapy with melatonin to reduce intraocular pressure.
  6. PUBLICATION ES2597827. Use of melatoninergic compounds to treat the ocular surface.
  7. PUBLICATION 2650981. Preparation and use of an extract of brine shrimp to treat the ocular surface.
  8. PUBLICATION US20190275089. Preparation and use of an extract of artemia salina to treat the ocular surface.
  9. PUBLICATION P3488855 Preparation and use of an extract of artemia salina to treat the ocular surface.
  10. PUBLICATION WO2018015582 Preparation and use of an extract of brine shrimp to treat the ocular surface.

Ocupharm Diagnostics S.L has its own facilities where both In-vitro and In-vivo tests are carried out.